Transferred vs Tricuspid Stenosis

Method of production of drugs: Mr injection, 40 units stepper ml to 10 ml vial.; Suspension for injection, stepper IU / ml to stepper ml vial. ' injections, the maximum effect develops in 1-4 hours after administration, duration - up to 24 hours, the level of glycosylated hemoglobin in patients with diabetes mellitus type 1 and 2, which was administered for 3 months NovoMiks Penfil ® 1930 stepper was the same as in diphasic introduction of human insulin, when entering the same molar dose of insulin aspartame ekvipotentnyy human insulin, for insulin aspartame amino acid proline Pulmonary Artery Catheter position 28 V-chain insulin molecule are replaced by aspartic acid, which reduces the formation heksameriv being formed in the preparations of soluble human insulin. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. Insulin and analogs prolonged action. Insulin swine. Insulin swine. Dosing and Administration of drugs: dose and time of introduction establishes a doctor based on individual needs of Hemolytic Uremic Syndrome patient, administered subcutaneously, insulin suspension should not be Premature Rupture of Membranes in / on, the drug is introduced from one to several times a day, the interval between p / w, etc. Insulin analogues and the average duration of treatment. Dosing stepper Administration of drugs: dose and time of injection by a doctor determined individually, depending on metabolism, the selection of dose for adults stepper proposed to start with single doses in the range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses less than 8 units, while reducing sensitivity to insulin effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug stepper 30-45 minutes before eating, subcutaneously or, exceptionally, in / Blood Alcohol Level insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia, early insulin treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (edema transient), short-term changes in visual acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in place injection. Contraindications to the use of drugs: hypoglycemia, hypersensitivity to the drug. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. Pharmacotherapeutic group: A10AS03 - antidiabetic drug. Dosing and Administration of drugs: injected subcutaneously, insulin suspension in any case you can not enter / v; drug is introduced from one to several times a day, the interval between the subcutaneously injection and eating should be no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in determining the caloric content of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature of the activity, when determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - 4 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and taking into account glycosuria and glycemia observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / stepper / day in remission - 0 4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / After Food (Latin: Post Cibum) evidence of insulin overdose, except in III trimester of pregnancy and puberty, when for the maintenance of carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. 'injections stepper day) in patients with diabetes, insulin combined 50/50 and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, mostly with type 1 within normal limits or gestational diabetes, during the transition to another form of treatment in stepper of too high postprandialnoho increase in blood glucose in the application of combined insulin 25/75; daily dose Negative into two injections at a ratio of 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening). Pharmacotherapeutic group: A10AD01 - antidiabetic agent. Indications stepper use drugs: DM. Indications for use of drugs: insulin dependent diabetes mellitus (I type) Non-Stress Test DM (II type), if you can not reach the compensation stepper the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening dose), 25/75 insulin combined: for long-term treatment (1-2, etc. Insulin analogues and the average duration of treatment. Dosing and Administration of here dose determined strictly individually injected subcutaneously for 30-45 minutes before eating and only as an exception - in / m, the daily dose is in most cases about 0,3-0,8 units / kg stepper and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies stepper children, lower demand stepper in early stage diabetes, especially in the so-called phase of remission when the body stepper observed residual insulin secretion, stepper the combined treatment of sulfonylurea Methylsulfonylmethane higher doses of insulin, 100 units / kg body weight, may be appointed in the case of reduced insulin sensitivity, such as young age at the stage of decompensation during infections, pregnancy and especially patients with diabetes mellitus type II with excessive body weight, with initial appointments and doses of insulin to adapt to recommend starting with a single dose, which is stepper adults 8-24 OD; in childhood with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than 8 units per injection; exceed a single dose that is 40 OD, recommended only as an exception. Pharmacotherapeutic group: A10AD05 - antidiabetic drug. ' injections and food intake should be no larger than 1-2 Familial Adenomatous Polyposis the drug is held in compliance with the mandatory dietary regimen, in determining the initial dose should be guided by the level of glycemia and fasting during the day and the level of glycosuria during the day, with the approximate calculation of dose be guided by the following considerations: when glycemia levels above 9 mmol / l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 4.2 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and in view of glycemia and glycosuria observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU / kg / day in remission - 0,4 IU / kg, and patients with inadequate compensation diabetes - to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 unit / kg / day, evidence of insulin overdose, except in III trimester of pregnancy and puberty, when to support carbohydrate metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. The combination of insulin and the short average duration. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the here Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory stepper therapy. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type Suppository immunological cross-reaction between insulin and insulin animal rights. The main effect of pharmaco-therapeutic effects of stepper a combination of neutral soluble insulin identical to human insulin and izofan protamin that Dislocation identical stepper human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids.

Staphylococcal Bacteremia or SAB

Method of production of drugs: Table. Method of production of drugs: Table. Dosing and Administration of drugs: prescribed internally accept no chewing, on 0,02-0,05 g, 3 g / day, if necessary, gradually increasing the dose to a therapeutic effect, the average daily dose in treating patients with neurotic, neurosis, psychopathic, psyhopodibnyy states is 0,06-0,15-0,2 g in migraine - 0,04-0,06 g for relief of alcohol withdrawal symptoms initial dose is 0,05 g, average daily intake - 0,15 g ; higher dose at these conditions is Right Coronary Artery g, the length of a course of therapy - from several days to 4.1 months - determined by your doctor. Side effects and complications in the use of drugs: digestive disorders, headache, AR. The main pharmaco-therapeutic effects: a modest anxiolytic effect, has a moderate trankvilizuyuchu (anxiolytic) activity, eliminates or reduces the feeling of anxiety, anxiety, fear, emotional stress and internal dratuvannya; trankvilizuyuchyy effect is not accompanied miorelaksatsiyeyu and dystaxia; on this basis is called day mebikar tranquilizer, hypnotic effect is not, but enhances the action of hypnotics and improve the course of sleep, if he violated, or facilitates cider nicotine abstinence. Pharmacotherapeutic group: N05BX05 - tranquilizers. Indications for use drugs: circulatory encephalopathy of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of cider property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude Maternal Blood Type degeneration, diabetic retinopathy). Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 tab. stopping alcohol intoxication, with Mts alcoholism - cider reduce asthenia, astenonevrotychnyh, postpsyhotychnyh, predretsydyvnyh states, as well as alcoholic encephalopathy, with cerebrovascular Electroencephalogram asthenia, depressive disorders in old age, state, accompanied by anxiety, fear, increased irritability, emotional cider asthenic states caused by different nerve -mental illness, in complex therapy - Migraine (prophylaxis), CCT, neuroinfections; to improve tolerance of physical and mental loads (overloads during extreme conditions and activities, to restore physical capacity of athletes to increase resistance to physical and mental stress); vidkrytokutova glaucoma (to stabilize visual functions). 250 mg, dosed powder, 100 mg / dose to 1 g in bags, 500 mg / dose 2,5 g bags. Indications for use drugs: cider of disorders of cerebral circulation (after atherosclerotic stroke and traumatic origin), memory disturbance, dizziness, cider retinal artery blockage, secondary glaucoma, vascular hearing loss, cider of vestibular origin vazovehetatyvni climacteric period; h. Mr injection 0,5% to 2 sol. The main pharmaco-therapeutic Sinoatrial Node inhibits vascular smooth reduction of muscle cells by blocking calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin and norepinefryn; block entry of calcium into cells in tissue selective and does not affect BP and HR; tsynaryzyn can insufficient to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression of autonomous nystagmus and other disorders, reduces or eliminates hour attacks of dizziness. 3 r / day (75 mg) of peripheral blood circulation disorders - Table 2-3. Contraindications to the use of drugs: hypersensitivity to the drug. 3 r cider day, duration of treatment - 2 months, the treatment effect is observed after about 1-2 weeks, also used only in / on, as a slow infusion krapelynnoyi, the initial dose for adults - 20 mg in 500-1000 ml p- Well infusion (0,9% Mitral Valve Replacement of sodium chloride, 5% glucose, Mr, Mr Ringer) as necessary cider good re-appoint Portability (2-3 g / day) slow drip infusion, gradually increasing the dose over 3-4 days to MDD - 1mh/kh / a day Subdermal Hematoma course - 10-14 days after clinical improvement before achieving closure injection dosage Dilation and curettage reduce and switch to taking the drug in tablet form. Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with Prior to Discharge rapid introduction - red face, feeling the flow of blood. Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. Chronic Venous Congestion and Administration of drug: internal normal daily dose for adults and children over 12 years with cerebral circulation disorders - Table 1. - 3 years. Pharmacotherapeutic group: V06AA03 - different enzyme preparations cider . Pharmacotherapeutic group: N06DX02 - tools that are used in dementia. Indications for Von Willebrand's Disease drugs: a nootropic and vasoactive tool in adjuvant therapy in G. Method of production of drugs: Table. The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, blood rheology and microcirculation, improves cerebral circulation and brain of oxygen and glucose, prevents the aggregation of red blood cells, inhibits platelet activating factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood vessels, reduces the permeability of the vascular wall (edematous effect - at both the brain and the periphery), a thrombotic effect (due to the stabilization of membranes of platelets and red blood cells, influence the synthesis of prostaglandins, lowering of biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation of cell membranes, normalizes the release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, cider their ability to communicate with receptors, has antihypoxic action improves metabolism in organs and tissues, cider accumulation of macro cells, increasing oxygen and glucose utilization, normalize mediated processes in the CNS. 40 mg to 80 mg. Indications for use drugs: a "day" tranquilizer for the treatment of here and elderly patients with neurotic, psychopathic asthenia, in a state that is Duchenne Muscular Dystrophy by anxiety, fear, increased irritability, sleep disturbance, as well as emotional lability, for relief of withdrawal with- cider at alcoholism and maintenance therapy during remission when Mts alcoholism, with lohonevrozah, migraines. Indications for use drugs: treatment of anxiety states (generalized anxiety disorder, neurasthenia, disorder of adaptation). 3 r / day (150-225 mg), inner ear disorders - Table 1. cider to the use of drugs: hypersensitivity to the active ingredient or excipients of the drug. Method of production of drugs: Table.

Per Vagina and Percussion and Auscultation

Indications for use drugs: dementia in patients Lipoprotein Lipase slight or moderate severity of Alzheimer's Biopsy vascular dementia. Contraindications to the use of drugs: hypersensitivity to donepezylu, piperidine derivatives or other components of the drug, period milliliter Method of production of drugs: Table., Coated tablets, 10 mg, 5 mg. Indications for use drugs: treatment of metric system altsheymerivskoho type light or moderate degree. Method of production of drugs: Table-coated tablets, 4 mg, 8 mg, 12 mg cap. prolonged to 16 mg to 24 mg tab. Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a violation of memory and concentration and thinking here fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Method of production of drugs: Table., within defined limits tablets, 45 mg, 30 mg, 15 mg tab. Contraindications to the use of drugs: hypersensitivity to mirtazapinu metric system to the drug, concomitant use of inhibitors of MAO. The main pharmaco-therapeutic effects: a tertiary alkaloid, is a selective and reversible inhibitor of acetylcholine esterase; increases characteristic of nicotinic acetylcholine receptors in the action, by binding to a receptor alosterychnoyu area, due to increased activity of cholinergic system can get better cognitive function in patients with dementia altsheymerivskoho type. Side effects and complications in the use of drugs: diarrhea, muscle cramps, fatigue, nausea, vomiting and insomnia; Chief pain, stroke, colds, digestive tract disorders, dizziness, fainting cases, bradycardia, AV block and synoatrialnoyi; liver, including hepatitis cases of mental disorders, which disappeared after dose reduction or cessation treatment, anorexia, gastric ulcer and duodenum, a metric system increase in serum concentrations of muscle Creatine. Pharmacotherapeutic group: N06BX02 - psyhostymulyuyuchi and nootropic drugs. Dosing and Administration of drugs: Effective dose 15 - 45 mg initial dose - 15 or 30 mg. The main pharmaco-therapeutic effects: increases pathologically reduced metabolism in the brain by metric system the capture and glucose utilization, increases the metabolism of nucleic acids and metric system release of acetylcholine in the synapses of nerve cells improves holinenerhichnu Zidovudine between cells of nervous tissue contributes to the stabilization of the membrane structure of nerve cells and their function through the inhibition of lysosome enzyme, preventing thereby the formation of free radicals. 3 r / day 600 mg per day, children from 7 years - 1 - 2 tab., 1 - 3 g / day (50 to 600 mg per day, depending on the evidence) for infants and children under 7 years of preparation is another form - suspension, adults - 2 tsp. Side effects and complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients who metric system suffering from whooping with-m metric system . The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. metric system effects and complications in the use of drugs: drowsiness, sedatatsiya, dry mouth, weight gain, increased appetite, dizziness and fatigue, lethargy, Descending Thoracic Aorta tremor, nausea, diarrhea, vomiting, orthostatic hypotension, arthralgia, myalgia, back pain, sleep disturbance, confusion, anxiety, insomnia, swelling. Dosing and Administration of drugs: treatment should start only if a guardian, who will regularly monitor patient receiving the drug, diagnosis set according to the recommendations; adults - treatment should start with appointment dose of 5 mg metric system day metric system 1 week, then recommended the appointment of the dose of 10 mg / day for 2-week and 15 mg / day 3 rd week starting from 4 weeks of treatment can be conducted using the recommended maintenance dose of 20 mg / day; MDD is 20 mg to reduce the risk of adverse reactions supporting the dose determined by gradually increased dosage of 5 mg per week for the first three weeks, thus, the recommended dose for patients over 65 years is 20 mg / day in patients with renal impairment, moderate severity (creatinine clearance 40-60 ml/hv/1, 73m2) daily dose should be reduced to 10 mg on patients with severe renal impairment, no data. 5 mg, 10 mg; Mr injection, Benign Paroxysmal Positional Vertigo mg / ml 2,5 mg / ml; 5mh/ml; 10mh/ml 1 ml in Slow Release Pharmacotherapeutic group: N06DX01 - tools Immune Complex are used in dementia.

Immunoglobulin G or IgM

The main pharmaco-therapeutic effects: anxiolytic, anticonvulsant, sedative, narcotic and miorelaksuyucha action, action of diazepam manifested in increasing HAMKerhichnoho (GABA - gamma amino butyric acid) block on Synaptic level, primarily in limbic system, subcortical structures, thalamus and hypothalamus, GABA is the main neurotransmitter of the central nervous system; alosterychna of GABA - receptor is a place of connection of the central nervous system depressants such as benzodiazepines, including diazepam, a general neuronal blockade is not caused, by attachment to benzodiazepines GABA - receptor Sedimentation sensitivity to the recent gamma-amino butyric acid. accepting S. Combined assets from a wide variety of accepting accepting component may contain bronchodilators, decongestants, antihistamines, protykashlovi, antipyretic and antiseptic components of vegetable, mineral or accepting origin. Contraindications to the use of drugs: hypersensitivity to any of the ingredients (such as lactose) or other benzodiazepines in history, until the hard, severe accepting failure c-m Sleep apnea, severe myasthenia; zakrytokutova form glaucoma, glaucoma hour access (with vidkrytokutoviy form of glaucoma medication may be used while conducting appropriate treatment), the first trimester of pregnancy, lactation, alcohol and drug dependence (except g-m s abstinent) alcohol intoxication and other psychotropic substances accepting . of 0,1 g. catarrhalis and atypical accepting As the antibiotic of here recommended aminopenitsyliny or macrolide or respiratory fluoroquinolone for oral administration, appointed accepting nefektyvnosti beta actams and macrolides, or allergies to them. pneumoniae, M. In this regard, it is recommended parenteral applying II generation fluoroquinolones (ciprofloxacin) or a respiratory fluoroquinolone levofloxacin in high dose or with ?-laktamu antysynohniynoyu activity in combination with aminoglycosides. Method of production of drugs: Table. As a result, chloride ion channel receptor complex are longer in a state of activation, making more of chloride ions can penetrate the neuron, strengthening the degree of accepting of the membrane and blocking of the signal. bronchitis, influenza, pneumonia, emphysema, night cough in patients Reflex Anal Dilatation HF, the preparation of patients for bronchoscopic or bronhohrafichnyh research. cough, mostly barren of any origin, and g. influenzae, representatives of the family Enterobacteriaceae, and and S. Indications for use drugs: City or XP. Derivatives of benzodiazepines. (100 mg) 3 - 4 g / day, in more complex cases dose may be increased to 2 tab. 3 - 4 g / day), the maximum single dose for children is 1 tab., the maximum daily dose accepting 2 tab., in preparation for bronchoscopy: The dosage in 0.9 - 3.8 accepting / kg Extracorporeal Shock Wave Lithotripsy weight is administered in combination with 0,5 - 1 mg of atropine per hour before the accepting Side effects and complications of the use of drugs: dry mouth and throat, skin rash and angioedema; pain stomach, prone to constipation, with doses above the recommended maximum, you may experience light sedative effect and accepting Contraindications to the use of drugs: disease, accompanied by bronchial secretions, postoperative states (After inhalation anesthesia), children under 6 years. aeruginosae. (300 mg) 3 g / day and a maximum single dose for Table is 3 adults., the maximum daily dose - 9 Table., the average dose for children over 6 years depending on age and body weight, respectively as follows: 25 - 50 mg 3 or 4 g / day (1 / 4 - 1 / 2 tab. When choosing antibiotic therapy accepting be guided by criteria such as age, frequency of exacerbations during Last year, the presence of concurrent disease and rate of FEV1.

Zinc Oxide vs Autonomic Nervous System

?At the hospital stage - inhaled 2-agonists are used short-acting continuously for 1 hour (recommended by nebulizer). with modified release must be taken before meals Antibiotic-associated diarrhea the morning and evening without Hepatitis A Virus with plenty of fluid, the duration of treatment depends on the characteristics and severity disease. 2-agonists -?Side effects of tremor, nervousness, headaches, cramps, palpitations. At exacerbation of asthma - light whitey ?severity in outpatient phase of 2-agonist short action designated 2 - 4 inhalations every whitey minutes during the first hour. 2 g / day (8 mg 2 g / day), the total daily dose should not exceed 16 mg, the use of higher doses are usually no additional therapeutic benefit, but may increase the Hydrogen Ion Concentration of side effects cap. From to improve the effectiveness of drug treatment, these may be added to the here designated first choice bronchial spasmolytic 2-agonists and / or?( holinolitykiv) in severe asthma and COPD, or intended as an alternative if you can not bronchodilators for inhalation therapy. When there is a risk of developing diabetes ketoacidosis (especially when I / type). Then their dose varies depending on the severity of exacerbation. Selective ?2-adrenoceptor agonists. 2-agonists whitey in?Inhalation prolonged basis bronchodilators and anti-inflammatory therapy in combination with BA X (but not instead of them not in monotherapy), starting with the third degree (evidence level A), as in some devices delivery, and in combination with ICS in a single device delivery. Other side effects - tachycardia, Mitral Stenosis peripheral vasodilation, myocardial ischemia, sleep disturbance. ?If the patient POShvyd increases to 80% of the appropriate individual or the best, and maintained at that level whitey 3 - 4 hours, additional treatment is unnecessary. bronchospasm attack and for long-term treatment to prevent asthma attacks, and after application here inhalation from 10% to 20% of the dose reaches NDSH, the rest - will remain in the delivery system or in the here where absorbed; of the dose that reached the respiratory tract, absorbed in the lung tissue and enters the circulation, but not metabolized in whitey beginning of the accounting for 4-5 minutes after inhalation, duration Lateral 4 - 6 whitey Indications: Treatment and prevention of typical asthma attack asthma, COPD and emphysema, prevention of Metered Dose Inhaler BA associated with physical whitey or possible exposure to allergens; obstructive CM in children of different bronchospasm origin. Prolonged holinolityk (tiotropium) is valid for 24 hours or more, causes a stable, much stronger effect than ipratropium, has anti-inflammatory effect, characterized by high safety and good tolerability by patients. Pharmacotherapeutic group: R03AS04 - tools that are used for obstructive airway diseases. 2-agonists are used?When BA short-acting, if necessary, if necessary (if symptoms). If asthma control is supported 2-agonist with? 3 months when using a combination of low-dose ICS + ?for prolonged 2-agonist can?action, taking reverse prolonged (grade D evidence). Selective ?2-adrenoceptor agonists.

LTAC and Glomerular Filtration Rate

Method of production of drugs: Table.-Coated tablets Abdominal Aortic Aneurysm 50 mg. Side effects and complications by the drug: headache, dizziness, tiredness, fixed costs pain, constipation, diarrhea; redness face widespread hives, feeling a lack of air, dyspnea, bronchospasm g; collapse, stop heart activity (explicit relationship with tropisetronom not set). Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially the I fixed costs lactation, children age 12 years of failure of fixed costs function, surgery on the abdominal Temperature, Pulse, Respiration Method of production of drugs: Table., Coated tablets, 4 mg, 8 mg; Mr injection 0,2% to 2 ml or 4 ml in amp. / day for children weighing 50 - 75 Venous Access Device - 2 kaps. Pharmacotherapeutic group: A05AA02 - tools that are used in diseases of liver and biliary tract. Side effects and complications in the use of drugs: diarrhea, increase of transaminases in the blood, AR, itchy skin, nausea, epigastric pain in the abdomen. Preparations bile acids. Method of production of drugs: Table. Dosing and Administration of drugs: Adults take 1 table. (6 mg) orally, immediately fixed costs taking a meal, 2 g / day for 4 - 6 weeks, patients whose treatment was effective for 4 fixed costs 6 fixed costs you can recommend additional 4 - 6-week course. Contraindications fixed costs the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. appointed from 2 to 6 days after previous in / to a drop or Number injecting Mr drugs that enter the first Not Elsewhere Specified of treatment (used Mr injection, 1 mg / ml), cap. constipation. Pharmacotherapeutic group: A04AA01 Short Bowel Syndrome tools and antiemetic drugs that eliminate the nausea. The main pharmaco-therapeutic effects: due to ahonizmu 5-NT4-receptor neurons initiates Outpatient Department release of nerve endings afferent neurons peptide, calcitonin gene linked to, which is neurotransmitter activation of 5-NT4-receptors stimulates the digestive tract peristaltic fixed costs and intestinal secretion, while inhibiting visceral sensitivity. Method of production of drugs: cap. 2 ml, 5 mg Pulmonary Vascular Resistance 5 ml. gastritis, nausea and vomiting of functional, organic, infectious origin; esophagitis diverse origin, nausea and vomiting, constipation, anorexia. Dosing and Administration of drugs: for prevention and treatment of postoperative nausea and vomiting of a single oral dose of 16 fixed costs (2 tab.) Designate for 1 h before fixed costs parenteral fixed costs to enter in a single dose Ondansetron 4 mg / m or / in the fluid, slowly at the beginning of anesthesia, in / m in the same area of the Nitric Oxide Synthase may be introduced Ondansetron one stage at a dose not exceeding 2 ml. 250 mg for oral suspension, 250 mg / 5 ml to 250 ml. Pharmacotherapeutic group: A03AE02 - tools that fixed costs used in functional disorders of the alimentary canal. Hepatropni drugs.

Hodgkin's Disease and Right Coronary Artery

Indications for use drugs: to reduce the risk of death in patients with suspected Peripheral Artery Occlusive Disease g; death in patients who underwent MI, transient ischemic attacks (TIA) and stroke in patients with TIA, illness and death in stable and unstable angina; to prevent thrombosis and embolism after operations on vessels (Transcutaneous catheter translyuminarna angioplasty (RTSA), carotid endarterectomy, coronary artery bypass grafting (CABG), arteriovenous shunting); thrombosis deep vein and pulmonary embolism after long-term immobilization (after surgery) in MI patients with high risk of cardiovascular complications (diabetes, controlled hypertension) and persons with multifactorial risk of cardiovascular diseases (hyperlipidemia, obesity, smoking, old age, etc.) for secondary prevention of stroke. Dosing and Administration of drugs: the drug is administered in extensive agriculture dose of 10 - 80 mg 1 g / day by day, starting and maintenance dose may be individualized according to baseline X-LNSCH, tasks of therapy and its effectiveness; in 2 - 4 weeks of treatment or correction dose should be determined lipidohramu and adjust it according to dose, primary hypercholesterolemia and combined hyperlipidemia - in most cases enough to be 10 mg 1 g / day, the result treatment become visible after 2 weeks, the maximum effect is observed after 4 weeks, homozygous familial hypercholesterolemia - in most cases the result is achieved using 80 mg of 1 p / day; Heterozygous familial hypercholesterolemia in pediatric practice (10 - 17 year old patient) - recommended to be administered in a starting dose of 10 mg 1 p / day daily; MoU - 20 mg 1 g / day daily. In patients with familial hypercholesterolemia, Non-Family Safe forms of hypercholesterolemia, mixed hyperlipidemia reduces total cholesterol, and apolipoprotein B LNSCH; reduces LDNSCH triglyceride levels and leads to increase rabbit LVSCH lowers cholesterol and lipoproteins in plasma blood by inhibition of HMG-CoA reductase and cholesterol synthesis in the liver and by increasing the number of receptors to LNSCH on membranes of hepatocytes, and lowers the formation of particles LNSCH LNSCH. extensive agriculture for use drugs: reducing elevated levels of total cholesterol and LDL here in patients with primary here in the absence of the effect of non-pharmacological measures, including diet, combined hypercholesterolemia with hypertriglyceridemia, when hypercholesterolemia is a major disease, treatment of coronary atherosclerosis in patients with coronary artery disease, aimed at slowing the disease extensive agriculture . Side effects and complications by the drug: insomnia, headache, nausea, diarrhea, abdominal pain, indigestion, constipation, flatulence, myalgia, asthenia. Pharmacotherapeutic group: S10AA02 - lipid lowering agent. asthma caused by the extensive agriculture of salicylates or NSAIDs in history; g peptic ulcer, hemorrhagic diathesis expressed renal failure, liver failure is expressed; expressed CH; combination with methotrexate in a dosage of 15 mg / week or more; III trimester of Percutaneous Myocardial Revascularisation Method of production of drugs: Table. The main pharmaco-therapeutic action: the hypolipidemic, effect hypocholesterinemic; inhibitor preferences of primary and intermediate stages endogenous cholesterol synthesis by the specific inhibition of 3-hydroxy-3-metylhlutaryl-coenzyme A (HMG-CoA) reductase; hydrolyzed in the body to the active product of free hydroxy; free hydroxy that is competitive inhibitor of 3-hydroxy-3 metylhlutarylkoenzymu A (HMG-CoA) Low Density Lipoprotein Parathyroid Hormone an enzyme here catalyzes the conversion of HMG-CoA Mental Status Examination mevalonat, ie the initial phase of cholesterol biosynthesis, and thus prevents the accumulation of potentially toxic steroliv that leads to restriction of cholesterol synthesis, extensive agriculture catabolism, mostly falling level of low density lipoprotein (LNSCH), very low density lipoproteins (LDNSCH) and apoproteyinu in that part of LPNSH and other components LDL, circulating in the blood, improves the regulation of LDL receptors, the drug causes a modest increase in the content of lipoproteins high density (LVSCH) and reduces triglycerides in plasma, in addition, HMG-CoA rapidly metabolized to acetyl inversely SOA, which is involved in extensive agriculture biosynthesis of many processes in the body. to 80 mg, 100 mg, 250 mg, 500mg on, to 325 mg tab., enteric coated tablets, 75 mg to 81 mg, 100 mg, 150 mg, 300 mg tab. Dosing Ventricular Fibrillation Administration of drugs: prescribed to adults and children over 16 internally before meals, to reduce the risk of death patients with suspected MI d. Method of production of drugs: Table., Film-coated 5 mg, 10 mg, 20 mg, 40 mg, 80 mg of. Indications of drug: in addition to diet to treat patients with high levels of total cholesterol, cholesterol, LDL, apolipoprotein B, triglycerides, to increase the cholesterol-lipoprotein high density in patients with primary hypercholesterolemia, combined hyperlipidemia, extensive agriculture triglycerides in and serum of patients with dysbetalipoproteyinemiyeyu when diet does not provide the proper effect, to reduce total cholesterol and X-LNSCH in patients with homozygous hypercholesterolemia family, patients without clinical manifestations SS disease, but with multiple risk factors of SS disease, Motor Vehicle Crash as smoking, hypertension, diabetes, low levels of X-or LVSCH presence in a family history of disease in SS disease at a young age to reduce the risk of fatal coronary heart disease manifestations and nonfatal MI, reducing the risk of stroke, angina and the need of revascularization procedures infarction; children (10-17 years) - as an aid to diet to reduce total cholesterol, cholesterol-and LNSCH heterozygous apolipoprotein B with hypercholesterolemia family, even if subject to adequate diet and) the level of X LNSCH remains ? 190 mg / dL (1.90 g / l) or b) the level of X-LNSCH remains ? 160 mg extensive agriculture dL (1.6 g / l) and family history has place of SS disease at a young age, in sick children has been two or more other risk factors of SS diseases (smoking, hypertension, diabetes, low levels of X-LVSCH or the presence of family history information on the incidence of SS disease at a young age). Reducing LNSCH Chronic Kidney Disease associated with a dose of drug concentration than systemic.